Science Advances

Supplementary Materials

This PDF file includes:

  • Fig. S1. Biochemical characterization of TtClpP.
  • Fig. S2. Characterization of GFPssrA degradation by TtClpXP.
  • Fig. S3. Characterization of TtClpP peptidase activity in the absence and presence of bortezomib.
  • Fig. S4. Characterization of FITC-casein degradation by TtClpP in the absence and presence of bortezomib and/or TtClpX.
  • Fig. S5. Ligand validation by 2mFo-DFc, omit, and polder maps.
  • Fig. S6. Distance RMSD of the 14 alanine tripeptide ligands with respect to their initial bound state in TtClpP for three independent, 1-μs-long MD simulations.
  • Fig. S7. Analysis of structural differences between TtClpP and EcClpP.
  • Table S1. Crystallographic data collection and refinement statistics.
  • Reference (65)

Download PDF

Files in this Data Supplement: